1. Home
  2. CADL vs UXIN Comparison

CADL vs UXIN Comparison

Compare CADL & UXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$8.83

Market Cap

578.8M

Sector

Health Care

ML Signal

HOLD

Logo Uxin Limited ADS

UXIN

Uxin Limited ADS

HOLD

Current Price

$2.26

Market Cap

495.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
UXIN
Founded
1999
2011
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
578.8M
495.0M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
CADL
UXIN
Price
$8.83
$2.26
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$19.00
N/A
AVG Volume (30 Days)
2.2M
100.4K
Earning Date
05-14-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
N/A
Revenue This Year
N/A
$245.77
Revenue Next Year
N/A
$44.72
P/E Ratio
N/A
$4.05
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$2.01
52 Week High
$9.27
$5.32

Technical Indicators

Market Signals
Indicator
CADL
UXIN
Relative Strength Index (RSI) 68.29 37.13
Support Level $4.80 $2.01
Resistance Level $9.27 $3.18
Average True Range (ATR) 0.60 0.15
MACD -0.04 0.01
Stochastic Oscillator 75.28 38.24

Price Performance

Historical Comparison
CADL
UXIN

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About UXIN Uxin Limited ADS

Uxin Ltd is an investment holding company. Along with its subsidiaries, the firm operates a car retailer, pioneering industry transformation with production, new retail experiences, and digital empowerment in China. With its inventory-owning model, it provides customers a comprehensive transaction solution that encompasses the entire value chain, ranging from used-car acquisition, inspection, and reconditioning, warehousing, as well as pre-sales and after-sales services. The group offers high-quality and value-for-money used cars as well as superior full suites of services to customers through a reliable, one-stop, and hassle-free transaction experience. It derives revenues from retail vehicle sales, wholesale vehicle sales, and other businesses. The Group generates its revenues in China.

Share on Social Networks: